Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Acta Dermatovenerol Croat ; 30(1): 49-53, 2022 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36153719

RESUMO

Skin changes in patients with diabetic foot (DF) are relatively common. The most frequent lesions feature papillae or cilia of various forms. The condition known as "verrucous skin lesions on the feet in diabetic neuropathy" (VSLDN) occurs in patients with distal diabetic sensorimotor neuropathy and is commonly located in places of high mechanical pressure. However, there is a scarcity of published data on the diagnosis and treatment of VSLDN. Our paper describes various types of VSLDN skin pathology, summarizes the diagnostic procedure options available, and documents the experience of our diabetic foot clinic in applying short-term VSLDN therapies as part of routine podiatric practice.


Assuntos
Diabetes Mellitus , Pé Diabético , Neuropatias Diabéticas , Verrugas , Pé Diabético/diagnóstico , Pé Diabético/etiologia , Pé Diabético/terapia , Neuropatias Diabéticas/complicações , Neuropatias Diabéticas/diagnóstico , Pé/patologia , Humanos , Pele/patologia , Verrugas/patologia
2.
Acta Dermatovenerol Croat ; 22(4): 291-3, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25580790

RESUMO

Hidradenitis suppurativa (HS) is a chronic, inflammatory disease characterized by recurring abscesses, nodules, and fistulas predominantly in the area of the groin and axillae. The association between HS and Crohn's disease (CD) has already been documented. We report on a case of a patient with CD associated HS, refractory to multiple local and systemic agents.A complete resolution of both diseases was finally achieved after treatment with adalimumab. Our case report supports the co-occurrence of both diseases and suggests that adalimumab approved for CD might also be a safe and effective therapeutic option in the treatment of HS.


Assuntos
Adalimumab/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Doença de Crohn/tratamento farmacológico , Hidradenite Supurativa/tratamento farmacológico , Doença Crônica , Doença de Crohn/complicações , Feminino , Hidradenite Supurativa/complicações , Humanos , Pessoa de Meia-Idade
3.
Acta Dermatovenerol Croat ; 21(4): 219-23, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24476607

RESUMO

Levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and tumor necrosis factor-α (TNF-α) may influence wound healing and wound closure in non-healing wounds. The aim of the study was to test the hypothesis that hydrogencalcium salts of oxidized cellulose change the production of matrix metalloproteinases (MMPs) and TNF-α, wound size and number of bacterial strains in non-healing wounds. We analyzed MMP-2, MMP-9 and TNF-α in the wound fluid from 20 patients by ELISA every fourteen days over six weeks. Wound size, pain, wound closure and bacterial strains in the wound were also investigated. The wound size was reduced in 14 patients and pain in 16 patients. Bacterial contamination of the wound decreased significantly after treatment. The level of MMP-2 correlated with TNF-α production. The level of MMP-9 was unchanged during the healing period. We conclude that hydrogencalcium salts of oxidized cellulose have a favorable effect on the reduction of bacterial contamination, wound size and pain.


Assuntos
Celulose Oxidada/farmacologia , Pé Diabético/metabolismo , Pé Diabético/terapia , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Úlcera Varicosa/metabolismo , Úlcera Varicosa/terapia , Cicatrização/fisiologia , Idoso , Pé Diabético/microbiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera Varicosa/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA